Brenipatide for moderate-to-severe COPD
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new medicine called Brenipatide to see if it can help people with moderate-to-severe COPD who still have symptoms despite using standard inhalers. The study will compare the effects of Brenipatide against a placebo to understand if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a COPD diagnosis for at least 12 months.
- You must be a current or former smoker with a smoking history of at least 10 pack-years.
- Your COPD must be moderate to severe, confirmed by breathing tests.
- You must have had at least 2 moderate or 1 severe COPD flare-ups in the past year.
- You must be on at least two inhalers (LABA+ LAMA or triple therapy) for at least 3 months, with a stable dose for at least 1 month.
- You must not have other significant lung diseases or recent active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called depemokimab for people with COPD and a specific type of inflammation (type 2). It aims to see if it can reduce flare-ups when added to standard inhaler therapy.
This study tests a new medication (GSK5784283) for people with moderate to severe COPD who have a certain type of inflammation (eosinophilic). Participants must be on standard inhaler therapy and have a history of smoking. The trial will compare the new drug to a placebo.
This study tests an investigational drug called Brenipatide for adults with major depressive disorder who are already on a stable antidepressant. You will receive the study drug as an injection and be monitored over time to see if it helps improve your depression symptoms.
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
This trial tests an injectable medicine called brenipatide to help people with moderate-to-severe alcohol use disorder reduce or stop drinking. It is for adults who are motivated to change their drinking habits.
This study tests an investigational drug called brenipatide for people with moderate to severe asthma that isn't well controlled by current medicines. The purpose is to see if it can reduce asthma attacks better than a placebo (inactive treatment).
Hear when a new Pulmonary Disease, Chronic Obstructive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.